Zymeworks Common Stock Stock Price on September 25, 2024
| ZYME Stock | USD 14.29 0.41 2.95% |
If you're considering investing in Zymeworks Stock, it is important to understand the factors that can impact its price. As of today, the current price of Zymeworks Common stands at 14.29, as last reported on the 22nd of January, with the highest price reaching 14.39 and the lowest price hitting 13.88 during the day. Zymeworks Common appears to be not too volatile, given 3 months investment horizon. Zymeworks Common Stock shows Sharpe Ratio of 0.0639, which attests that the company had a 0.0639 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Zymeworks Common Stock, which you can use to evaluate the volatility of the company. Please utilize Zymeworks Common's Downside Deviation of 3.35, market risk adjusted performance of 0.3545, and Mean Deviation of 2.67 to validate if our risk estimates are consistent with your expectations.
Zymeworks Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Zymeworks |
Sharpe Ratio = 0.0639
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZYME | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.74 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 5 95% of assets perform better |
Based on monthly moving average Zymeworks Common is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zymeworks Common by adding it to a well-diversified portfolio.
Related Headline
Relay Therapeutics Headline on 25th of September 2024
Disposition of 1657 shares by Peter Rahmer of Relay Therapeu... by Peter Rahmer
Filed transaction by Relay Therapeutics Officer See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Zymeworks Common Valuation on September 25, 2024
It is possible to determine the worth of Zymeworks Common on a given historical date. On September 25, 2024 Zymeworks was worth 12.51 at the beginning of the trading date compared to the closed value of 12.51. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zymeworks Common stock. Still, in general, we apply an absolute valuation method to find Zymeworks Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zymeworks Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zymeworks Common's related companies.
| Open | High | Low | Close | Volume | |
| 12.78 | 12.84 | 12.47 | 12.50 | 438,688 | |
09/25/2024 | 12.51 | 12.65 | 12.39 | 12.51 | 341,395 |
| 12.58 | 12.65 | 12.46 | 12.47 | 269,035 |
| Backtest Zymeworks Common | | | Zymeworks Common History | | | Zymeworks Common Valuation | Previous | Next |
Zymeworks Common Trading Date Momentum on September 25, 2024
| On September 26 2024 Zymeworks Common Stock was traded for 12.47 at the closing time. The top price for the day was 12.65 and the lowest listed price was 12.46 . The trading volume for the day was 269 K. The trading history from September 26, 2024 was a factor to the next trading day price decrease. The trading date delta against the next closing price was 0.32% . The trading date delta against the current closing price is 0.32% . |
Zymeworks Common Stock Fundamentals Correlations and Trends
By evaluating Zymeworks Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zymeworks Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zymeworks financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Zymeworks Common Stock history
Zymeworks Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zymeworks is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zymeworks Common Stock will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zymeworks Common stock prices may prove useful in developing a viable investing in Zymeworks Common
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada. Zymeworks operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 284 people.
Zymeworks Common Stock Technical Analysis
Zymeworks Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Zymeworks Common Period Price Range
Low | January 22, 2025
| High |
0.00 | 0.00 |
Zymeworks Common Stock cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Zymeworks Common January 22, 2025 Market Strength
Market strength indicators help investors to evaluate how Zymeworks Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zymeworks Common shares will generate the highest return on investment. By undertsting and applying Zymeworks Common stock market strength indicators, traders can identify Zymeworks Common Stock entry and exit signals to maximize returns
Zymeworks Common Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zymeworks Common's price direction in advance. Along with the technical and fundamental analysis of Zymeworks Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zymeworks to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.056 | |||
| Jensen Alpha | 0.1852 | |||
| Total Risk Alpha | 0.0851 | |||
| Sortino Ratio | 0.052 | |||
| Treynor Ratio | 0.3445 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |